SRTS

Sensus Healthcare Inc

SRTS, USA

Sensus Healthcare, Inc. operates as a medical device company that manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides SRT-100 Plus; Sentinel service program, which offers its customers protection for their systems; and Transdermal Infusion system, a biophysical alternative to infuse high weight molecule modalities into the dermis for medical and aesthetic purposes without the use of needles. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons and eye shields, ultrasound probe film, and disposable applicator tips to treat various sized lesions and various areas of the body. Further, the company distributes laser devices, such as applications for hair removal, vascular lesions, acne treatment, skin toning, and skin rejuvenation, as well as epidermal pigment removal for spots, freckles, and tattoos. It markets its products primarily to private dermatology practices, and radiation oncologists in both private and hospital settings. The company was incorporated in 2010 and is based in Boca Raton, Florida.

https://sensushealthcare.com

Stock Price

$ 0.00

0% decrease compared to yesterday.

Dividend

Frequency:

N/A

Rate:

N/A

Next Payout:

N/A
SRTS
stock
SRTS

Sensus Healthcare, Inc. $SRTS Shares Bought by Divisadero Street Capital Management LP MarketBeat

Read more →
SRTS
stock
SRTS

Sachetta Eric buys $27k in Sensus Healthcare shares Investing.com

Read more →

Showing 2 of 10

Analyst Ratings & Sentiment

(Last Updated 2025-09-30)

Rating:

BUY

Target Price:

$7.3333

Analyst Picks

Strong Buy

2

Buy

3

Hold

0

Sell

0

Strong Sell

0

Sentiment:

Bullish

Finn Analysis

(Last Updated 2025-09-30)

Health Score

Price to Book Ratio (P/B)

-

Very Low

1.22

Low ≤ 1

High ≥ 3

Return on Equity (ROE)

-

Very Low

-1.84 %

Low ≤ 5%

High ≥ 25%

Return on Assets (ROA)

-

Very Low

-1.62 %

Low ≤ 2%

High ≥ 10%

Free Cash Flow - Revenue % (FCF)

-

Very High

32.84 %

Low ≤ 5%

High ≥ 15%

Debt to Equity

-

Very High

0.14

Low ≥ 1

High ≤ 0.3

Investors

* Institutions hold a combined 33.46% of the total shares of Sensus Healthcare Inc

1.

Vanguard Group Inc

(4.5013%)

since

2025/06/30

2.

Dimensional Fund Advisors, Inc.

(3.6647%)

since

2025/06/30

3.

Vanguard Total Stock Mkt Idx Inv

(3.0057%)

since

2025/07/31

4.

Pacific Ridge Capital Partners, LLC

(2.7662%)

since

2025/06/30

5.

Divisadero Street Capital Management, LP

(1.9749%)

since

2025/06/30

6.

Renaissance Technologies Corp

(1.5215%)

since

2025/06/30

7.

Adara Smaller Companies

(1.1207%)

since

2025/07/31

8.

Geode Capital Management, LLC

(0.9362%)

since

2025/06/30

9.

Bank of New York Mellon Corp

(0.8768%)

since

2025/06/30

10.

Vanguard Institutional Extnd Mkt Idx Tr

(0.8667%)

since

2025/07/31

11.

M3Sixty Income and Opportunity Instl

(0.8516%)

since

2025/06/30

12.

Sachetta LLC

(0.7827%)

since

2025/06/30

13.

Perritt Capital Management Inc.

(0.7639%)

since

2025/06/30

14.

Perritt MicroCap Opportunities Investor

(0.7639%)

since

2025/06/30

15.

DFA US Targeted Value I

(0.6101%)

since

2025/07/31

16.

Meros Investment Management, LP

(0.6035%)

since

2025/06/30

17.

UBS Group AG

(0.598%)

since

2025/06/30

18.

Susquehanna International Group, LLP

(0.5215%)

since

2025/06/30

19.

Northern Trust Corp

(0.5184%)

since

2025/06/30

20.

DFA US Small Cap Value I

(0.5121%)

since

2025/07/31

21.

Dimensional US Targeted Value ETF

(0.4973%)

since

2025/08/29

22.

Dimensional US Small Cap Value ETF

(0.4919%)

since

2025/08/29

23.

Fidelity Extended Market Index

(0.4423%)

since

2025/07/31

24.

GSA Capital Partners LLP

(0.4361%)

since

2025/06/30

25.

BlackRock Inc

(0.4343%)

since

2025/06/30

26.

State Street Corp

(0.4006%)

since

2025/06/30

27.

DFA US Small Cap I

(0.3524%)

since

2025/07/31

28.

Evernest Financial Advisors LLC

(0.3272%)

since

2025/06/30

29.

Morgan Stanley - Brokerage Accounts

(0.2989%)

since

2025/06/30

30.

Two Sigma Investments LLC

(0.2794%)

since

2025/06/30

31.

Dimensional US Small Cap ETF

(0.2521%)

since

2025/08/29

32.

O'Shaughnessy Asset Management LLC

(0.2516%)

since

2025/06/30

33.

iShares Micro-Cap ETF

(0.1924%)

since

2025/08/31

34.

DFA US Micro Cap I

(0.186%)

since

2025/07/31

35.

RBC Microcap Value I

(0.177%)

since

2025/06/30

36.

Fidelity Total Market Index

(0.1515%)

since

2025/07/31

37.

Extended Equity Market Fund K

(0.1429%)

since

2025/06/30

38.

DFA US Core Equity 2 I

(0.1368%)

since

2025/07/31

39.

Dimensional US Core Equity 2 ETF

(0.1313%)

since

2025/08/29

40.

Avantis US Small Cap Equity ETF

(0.1218%)

since

2025/08/30

* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.

Earnings History

EPS ActualEPS EstimateEPS DifferenceSurprise Percent

Upcoming Earnings Release

Date

2025-12-31

EPS Estimate

-0.0433

Latest Release

Date

2025-09-30

EPS Actual

-0.06

EPS Estimate

-0.08

EPS Difference

0.02

Surprise Percent

25%

Investing Fit Scorecard

(Last Updated 2025-09-30)

Deep Value
Strong Deep Value(7)
Defensive
Highly Defensive(7)
Dividend
Weak Dividend Profile(3)
Economic Moat
Wide Moat Company(6.8)
GARP
Fair GARP(4)
Growth
Weak Growth Prospect(2.5)
Momentum
Moderate Momentum(4.5)
Net Net
Possible Net-Net(4.5)
Quality
Moderate Quality(4.5)
Value
Fair Value(5)

Income Statement

(Last Updated 2025-09-30)

Revenue

$ 0

Cost Of Revenue

$ 0

Gross Profit

$ 0

Operating Expenses

$ 0

Operating Income

$ 0

Interest Expense

$ 0

Pretax Income

$ 0

Net Income

$ 0

Income Tax Expense

$ 0

EBITDA

$ 0

Total Other Income Expense Net

$ 0

Earnings Per Share

0

Dividends Per Share

0

Shares Outstanding

0

Operating Margin

0%

Trend

Balance Sheet

(Last Updated 2025-09-30)

Cash

$ 0

Short Term Investments

$ 0

Receivables

$ 0

Inventories

$ 0

Total Current Assets

$ 0

Property Plant Equipment

$ 0

Total Assets

$ 0

Payables

$ 0

Short Term Debt

$ 0

Long Term Debt

$ 0

Total Liabilities

$ 0

Equity

$ 0

Trend

Cash Flow

(Last Updated 2025-09-30)

Net Income

$ 0

Depreciation

$ 0

Change In Working Capital

$ 0

Cash From Operations

$ 0

Capital Expenditures

$ 0

Cash From Investing

$ 0

Cash From Financing

$ 0

Net Change In Cash

$ 0

Trend

Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.